Genertec Universal Medical Group Company Limited

Symbol: UMTAF

PNK

0.595

USD

Market price today

  • 3.9347

    P/E Ratio

  • 0.5509

    PEG Ratio

  • 1.02B

    MRK Cap

  • 0.57%

    DIV Yield

Genertec Universal Medical Group Company Limited (UMTAF) Financial Statements

On the chart you can see the default numbers in dynamics for Genertec Universal Medical Group Company Limited (UMTAF). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Genertec Universal Medical Group Company Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019

balance-sheet.row.cash-and-short-term-investments

2180.07507497517.2
413.5
563.7

balance-sheet.row.short-term-investments

77.59821.627.1
37.8
35.5

balance-sheet.row.net-receivables

38501.119481.49395.29541.2
8319.5
7153.7

balance-sheet.row.inventory

210.6260.85441.6
30.3
22.5

balance-sheet.row.other-current-assets

-40891.79-10049.1-9946.2-10100
-8763.3
-7740

balance-sheet.row.total-current-assets

90142.11028090.924992.6
21832.5
20714.3

balance-sheet.row.property-plant-equipment-net

2782.07782.7709.3520.4
475.5
403.8

balance-sheet.row.goodwill

84.4340.414.716
10.7
10

balance-sheet.row.intangible-assets

78.64026.116
10.7
10

balance-sheet.row.goodwill-and-intangible-assets

163.0740.440.832.1
21.4
20.1

balance-sheet.row.long-term-investments

627.06146.8142.7133.9
71.8
96.1

balance-sheet.row.tax-assets

407.9999106.888
61
44.3

balance-sheet.row.other-non-current-assets

145405.48184.747780.344132.7
39048.9
36574

balance-sheet.row.total-non-current-assets

149385.681253.748779.844907.2
39678.5
37138.3

balance-sheet.row.other-assets

-194037.5210071.9-65822.8-58935.4
-52105.4
-49547.2

balance-sheet.row.total-assets

45490.2711325.51104810964.4
9405.6
8305.3

balance-sheet.row.account-payables

6834.5802247.21112
868.4
1289.4

balance-sheet.row.short-term-debt

12265.183313.23078.22313
3035.3
2151.6

balance-sheet.row.tax-payables

310.91084221.1
129.4
122.1

balance-sheet.row.long-term-debt-total

16999.563740.93955.44766.1
3105.5
3265.8

Deferred Revenue Non Current

223.45185.637.825.3
26.3
19.3

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-

balance-sheet.row.other-current-liab

34767.94-181.52101715282.9
19391.1
15297.6

balance-sheet.row.total-non-current-liabilities

107339.034838.130789.433545.2
23226
25647.4

balance-sheet.row.other-liabilities

-153450.34492.6-48712.9-43804
-39175.7
-37793.3

balance-sheet.row.capital-lease-obligations

732.36492.626.2122.3
225.4
275.6

balance-sheet.row.total-liab

35313.448643.88454.98472.6
7370
6612.1

balance-sheet.row.preferred-stock

0000
0
0

balance-sheet.row.common-stock

3028.15746.7761.3830.9
661.8
621.3

balance-sheet.row.retained-earnings

4124.871157.7999.7923.5
838.4
641.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

1063.75294.9246.8289.2
146.8
99.5

balance-sheet.row.other-total-stockholders-equity

10.6410.600
0
0

balance-sheet.row.total-stockholders-equity

8227.4122102007.82043.6
1646.9
1362.3

balance-sheet.row.total-liabilities-and-stockholders-equity

45490.2711325.51104810964.4
9405.6
8305.3

balance-sheet.row.minority-interest

1903.06425.4585.3448.2
388.8
331

balance-sheet.row.total-equity

10130.472635.42593.12491.9
2035.7
1693.3

balance-sheet.row.total-liabilities-and-total-equity

45490.27---
-
-

Total Investments

704.65154.8164.3161
109.6
131.6

balance-sheet.row.total-debt

29997.117546.77059.87201.4
6366.2
5692.9

balance-sheet.row.net-debt

27894.637047.76584.46711.4
5990.5
5164.7

Cash Flow Statement

The financial landscape of Genertec Universal Medical Group Company Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019

cash-flows.row.net-income

568.63285.9281.3283.6
238.8
216.7

cash-flows.row.depreciation-and-amortization

136.4971.765.349.4
39.2
20.4

cash-flows.row.deferred-income-tax

00-716.8-1113.8
-866.3
0

cash-flows.row.stock-based-compensation

000.45.8
5.8
0

cash-flows.row.change-in-working-capital

-493.89-55.4-462.1-920.6
-724.6
-823.1

cash-flows.row.account-receivables

-976.16-343.1-671.5-1027.6
-706.2
-803

cash-flows.row.inventory

-0.856.7-7.7-8.1
-3.4
-4.6

cash-flows.row.account-payables

166.678.893.326.4
-72.6
10.3

cash-flows.row.other-working-capital

316.52202.1123.888.7
57.6
-25.7

cash-flows.row.other-non-cash-items

176.3778.4843.81218.5
892.9
40.2

cash-flows.row.net-cash-provided-by-operating-activities

387.6000
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-211.1-126.9-90.5-59.5
-58.2
-30.3

cash-flows.row.acquisitions-net

20.02-41.462.87.4
13
68.5

cash-flows.row.purchases-of-investments

-245.76-232.1-20.5-84.1
-24
-67.7

cash-flows.row.sales-maturities-of-investments

109.0183.728.435.8
14.1
16.7

cash-flows.row.other-investing-activites

000-2.3
0
0

cash-flows.row.net-cash-used-for-investing-activites

-327.83-316.8-19.7-102.7
-55.1
-12.8

cash-flows.row.debt-repayment

-3337.92-129.3-52.7-779.1
-241.1
-407.2

cash-flows.row.common-stock-issued

000969.4
0
0

cash-flows.row.common-stock-repurchased

000-721.5
0
0

cash-flows.row.dividends-paid

-184.29-83.8-86.4-74.6
-65.8
-59.3

cash-flows.row.other-financing-activites

266.6412.7200.91236.1
587.5
1186.7

cash-flows.row.net-cash-used-provided-by-financing-activities

12.51-42.261.8630.2
280.5
720.2

cash-flows.row.effect-of-forex-changes-on-cash

-52.282-25.2-21.1
-46.5
101.9

cash-flows.row.net-change-in-cash

8.9823.6-14.6114.4
-152.6
147.3

cash-flows.row.cash-at-end-of-period

2102.48499475.4490
375.7
528.2

cash-flows.row.cash-at-beginning-of-period

2093.5475.4490375.7
528.2
380.9

cash-flows.row.operating-cash-flow

387.6380.611.9-477
-414.3
-545.8

cash-flows.row.capital-expenditure

-211.1-126.9-90.5-59.5
-58.2
-30.3

cash-flows.row.free-cash-flow

176.5253.7-78.6-536.5
-472.5
-576.1

Income Statement Row

Genertec Universal Medical Group Company Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of UMTAF is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019

income-statement-row.row.total-revenue

3849.391972.91805.11542.1
1239.5
1004.7

income-statement-row.row.cost-of-revenue

1732.151034.1811.6671.1
509.2
276.4

income-statement-row.row.gross-profit

2117.24938.8993.6870.9
730.3
728.3

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

0---
-
-

income-statement-row.row.selling-general-administrative

0---
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.other-expenses

-467.5-238.7-239.4-184.3
-140.8
-134

income-statement-row.row.operating-expenses

467.5238.7239.4184.3
140.8
134

income-statement-row.row.cost-and-expenses

2196.051272.81051855.5
650
684.4

income-statement-row.row.interest-income

007456.7
43.6
91.3

income-statement-row.row.interest-expense

797.44327.4302.8265.9
254.2
273.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.total-other-income-expensenet

-843.1-295.5-353.6-272.7
-248.4
-272.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

-467.5-238.7-239.4-184.3
-140.8
-134

income-statement-row.row.total-operating-expenses

-843.1-295.5-353.6-272.7
-248.4
-272.8

income-statement-row.row.interest-expense

797.44327.4302.8265.9
254.2
273.9

income-statement-row.row.depreciation-and-amortization

136.4971.765.349.4
39.2
20.4

income-statement-row.row.ebitda-caps

1786.24---
-
-

income-statement-row.row.operating-income

1649.74700.1754.2686.6
589.5
594.2

income-statement-row.row.income-before-tax

806.64404.6400.6413.9
341.1
321.4

income-statement-row.row.income-tax-expense

186.4294.491.8102.2
79.9
84

income-statement-row.row.net-income

568.63285.9281.3283.6
238.8
216.7
Similar Stocks
You may also be interested in:

Frequently Asked Question

What is Genertec Universal Medical Group Company Limited (UMTAF) total assets?

Genertec Universal Medical Group Company Limited (UMTAF) total assets is 11325532694.000.

What is enterprise annual revenue?

The annual revenue is 2048804462.000.

What is firm profit margin?

Firm profit margin is 0.579.

What is company free cash flow?

The free cash flow is 0.132.

What is enterprise net profit margin?

The net profit margin is 0.140.

What is firm total revenue?

The total revenue is 0.437.

What is Genertec Universal Medical Group Company Limited (UMTAF) net profit (net income)?

The net profit (net income) is 285905117.000.

What is firm total debt?

The total debt is 7546677485.000.

What is operating expences number?

The operating expences are 238692500.000.

What is company cash figure?

Enretprise cash is 498996708.000.